Addressing the Nutritional Needs of Cancer Survivors With Nutrition Insecurity

NCT ID: NCT06602999

Last Updated: 2025-06-10

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 42 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-02-04
• Study Completion Date: 2025-04-30

Brief Summary

This clinical trial studies whether the use of a grocery delivery service (Instacart) and nutrition navigation improves food insecurity in cancer survivors. The American Cancer Society recommends a normal body mass index, regular physical activity, and a healthy diet for cancer patients. Following these guidelines may help prevent deaths among cancer patients, but few cancer patients follow them. One reason for not following the guidelines could be due to the lack of consistent access to sufficient quantities of affordable, nutritious food for an active, healthy life (food insecurity). Instacart provides users access to foods that fall under the nutrition plan for cancer survivors that can be purchased and delivered to the user's home from many different grocery stores. Nutrition navigation provides support to cancer survivors via weekly check ins to help with following nutrition guidelines and assist with ordering groceries on the Instacart platform. Using a grocery delivery service, such as Instacart, and nutrition navigation may help improve food insecurity in cancer survivors.

Detailed Description

PRIMARY OBJECTIVE:

I. To determine the intervention's feasibility and acceptability.

SECONDARY OBJECTIVES:

I. To estimate the effect of the intervention on adherence to American Cancer society nutrition guidelines.

II. To estimate the effect of the intervention on self-reported food insecurity.

III. To evaluate the feasibility of patient navigation calls. IV. To evaluate the feasibility of Instacart vouchers.

EXPLORATORY OBJECTIVE:

I. To evaluate the feasibility of the intervention through an end-of-study semi-structured interview.

OUTLINE:

Patients receive a booklet on nutrition and physical activity for cancer survivors and 1 Instacart grocery delivery voucher to use over 4 weeks on study. Patients also receive nutrition navigation phone calls for assistance with following nutrition guidelines and ordering groceries on Instacart once a week (QW) for 4 weeks.

After completion of study intervention, patients are followed up at 28 days.

Conditions

Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Supportive Care (Instacart voucher, nutrition navigation)

Participation receive a booklet on nutrition and physical activity for cancer survivors and 1 Instacart grocery delivery voucher to use over 4 weeks on study. Participation also receive nutrition navigation phone calls for assistance with following nutrition guidelines and ordering groceries on Instacart every week for 4 weeks.

Group Type: EXPERIMENTAL

Nutritional Intervention

Intervention Type: OTHER

Receive a booklet on nutrition and physical activity for cancer survivors

Instacart Voucher

Intervention Type: OTHER

Receive Instacart grocery delivery voucher

Telephone-Based Intervention

Intervention Type: BEHAVIORAL

Receive nutrition navigation phone calls

Interventions

Nutritional Intervention

Receive a booklet on nutrition and physical activity for cancer survivors

Intervention Type: OTHER

Instacart Voucher

Receive Instacart grocery delivery voucher

Intervention Type: OTHER

Telephone-Based Intervention

Receive nutrition navigation phone calls

Intervention Type: BEHAVIORAL

Other Intervention Names

Nutritional Intervention

Eligibility Criteria

Inclusion Criteria

• Age > 18 years
• Diagnosis of a malignant cancer (except non-melanoma skin cancer).
• Not on active treatment at the time of screening and not expected to receive active anticancer therapy (e.g., surgery, radiation, chemotherapy, immunotherapy, targeted therapies) during the study period. Hormonal therapies are allowed for patients with breast or prostate cancer
• At least 6 weeks since a major surgery and fully recovered.
• Have access to the internet and able to send and receive text messages.
• Able to speak/read English.
• Based on the United States Department of Agriculture (USDA) United States (U.S.) Household Food Security Survey, identify as experiencing food insecurity and/or belong to a population that the National Institutes of Health (NIH) has identified as being at risk for health disparities:

• Identify as a racial or ethnic minoritized group, as defined by the NIH (American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Pacific Islander, Latino or Hispanic)
• Identify with a sexual or gender minoritized group.
• Annual household income < 200% of the federal poverty definition and/or education < bachelor's degree.
• Live in a rural and/or a persistent poverty area (based on zip code).

Exclusion Criteria

• Contraindication to any study-related procedure or assessment.
• Planned major surgery or cancer-directed therapy during the study period.
• Living outside of the US or Canada during screening and/or the study period (outside the geographic areas that Instacart covers).

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Cancer Institute (NCI)

NIH

Sponsor Role: collaborator

Stanford University

OTHER

Sponsor Role: collaborator

University of California, San Francisco

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Sorbarikor Piawah, MD

Role: PRINCIPAL_INVESTIGATOR

University of California, San Francisco

Locations

Zuckerberg San Francisco General

San Francisco, California, United States

University of California, San Francisco

San Francisco, California, United States

Countries

United States

Provided Documents

Document Type: Informed Consent Form

View Document

Other Identifiers

NCI-2024-07163

Identifier Type: REGISTRY

Identifier Source: secondary_id

U54CA280811

Identifier Type: NIH

Identifier Source: secondary_id

View Link

24806

Identifier Type: -

Identifier Source: org_study_id